期刊论文详细信息
BMC Cardiovascular Disorders
Economic burden of acute coronary syndrome in South Korea: a national survey
Aeree Sohn1  Taejin Lee2  Eunhee Lee3  Jinhyun Kim3 
[1] Department of Health Management, Sahmyook University, Seoul, Korea;Graduate School of Public Health, Seoul National University, Seoul, Korea;College of Nursing/The Research Institute of Nursing Science, Seoul National University, 28 Yeongeon-dong, Jongro-gu, Seoul, Republic of Korea
关键词: Ischemic heart disease;    Myocardial infarction;    Unstable angina;    Cost of disease;    Acute coronary syndrome;   
Others  :  857569
DOI  :  10.1186/1471-2261-13-55
 received in 2013-02-16, accepted in 2013-08-06,  发布年份 2013
PDF
【 摘 要 】

Background

Acute coronary syndrome (ACS) is highly prevalent in Korea and is the third-leading cause of death in Korea; however, the economic cost of ACS on Korean society has not been investigated. This study examined the economic effect of ACS on the Korean population during the period 2004 to 2009.

Methods

The analysis used the cost of illness (COI) framework. Data on direct medical costs, direct non-medical costs, and productivity loss related to ACS morbidity and mortality were included. The Korean National Health Insurance Corporation’s claim database was used to obtain data on annual healthcare utilization and expenditures for the entire South Korean population. By using a data mining technique, we identified healthcare claims with ACS-related disease codes. Costs were estimated by using a macro-costing method.

Results

In 2009, the prevalence of ACS in Korea was 6.4 persons per 1,000 population members and the associated mortality rate was 20.2 persons per 100,000 population members. The total cost of ACS in 2009 was USD 918.2 million. Of the total, direct medical cost was USD 425.3 million, direct non-medical cost was USD 11.4 million, and cost associated with morbidity and mortality was USD 481.5 million.

Conclusions

The results show that the total cost of ACS to the Korean society is high. Early and effective management of ACS is required to reduce ACS-associated mortality and morbidity. We suggest that further research be undertaken to determine ways to reduce the economic effects of ACS and its treatment.

【 授权许可】

   
2013 Kim et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140723082439307.pdf 369KB PDF download
81KB Image download
【 图 表 】

【 参考文献 】
  • [1]Korean National Statistics Office Database. http://kostat.go.kr/portal/korea/kor_nw/2/6/2/index.board?bmode=read&aSeq=66244 webcite [Accessed on 13 March 2011]
  • [2]Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguscon TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, et al.: Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
  • [3]Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, et al.: Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117:e25-e146.
  • [4]Yusuf S, Reddy S, Ounpuu S, Anand S: Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001, 104:2746-2753.
  • [5]Jung YH: Cost of illness and health-friendly fiscal policy. Health and Welfare Policy Forum 2009, 156:50-61.
  • [6]Moebus S, Balijepalli C, Lösch C, Göres L, Von Stritzky B, Bramlage P, Wasem J, Jöckel KH: Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study. Cardiovasc Diabetol 2010, 9:34. BioMed Central Full Text
  • [7]Kim JY: Construction of national surveillance system for cardiovascular & cerebrovascular disease. Seoul: Health Insurance Cooperation Health Insurance Review & Assessment Service; 2006.
  • [8]Byford S, Torgerson DJ, Raftery J: Economic note: cost of illness studies. BMJ 2000, 320:1335.
  • [9]Koopmanschap MA: Cost-of-illness studies. Useful for health policy? Pharmacoeconomics 1998, 14:143-148.
  • [10]Korean National Health Insurance Cooperation Health Insurance Review & Assessment Service: Health insurance statistical yearbook. Seoul; 2008.
  • [11]Kim JH, Jung JC, Kim SO: A study on individual co-payment for health insurance in Korea. Seoul: Korean National Health Insurance Cooperation; 2008.
  • [12]The Korean Association for Survey Research Database. http://knhanes.cdc.go.kr webcite [Accessed on 13 March 2011]
  • [13]Koopmanschap MA, Rutten FF: Indirect costs in economic studies: confronting the confusion. Pharmacoeconomics 1993, 4:446-454.
  • [14]Korean Ministry of Employment and Labor Database. http://www.moel.go.kr/english/statistics/MOL_Survey_Data.jsp webcite [Accessed on 13 March 2011]
  • [15]Smith DH, Gravelle H: The practice of discounting in economic evaluations of healthcare interventions. Int J Technol Assess Health Care 2001, 7:236-243.
  • [16]Bramkamp M, Radovanovic D, Erne P, Szucs TD: Determinants of costs and the length of stay in acute coronary syndromes: a real life analysis of more than 10,000 patients. Cardiovasc Drugs Ther 2007, 21:389-398.
  • [17]Etemad LR, McCollam PL: Total first-year costs of acute coronary syndrome in a managed care setting. J Manag Care Pharm 2005, 11:300-306.
  • [18]Kauf TL, Velazquez EJ, Crosslin DR, Weaver WD, Diaz R, Granger CB, McMurray JL, Rouleau JL, Aylward PE, White HD, et al.: The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J 2006, 151:206-212.
  • [19]Kolansky DM: Acute coronary syndromes: morbidity, mortality, and pharmacoeconomic burden. Am J Manag Care 2009, 15:S36-S41.
  • [20]Menzin J, Wygant G, Hauch O, Jackel J, Friedman M: One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin 2008, 24:461-468.
  • [21]Russell MW, Huse DM, Drowns S, Hamel EC, Hartz SC: Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998, 81:1110-1115.
  • [22]Turpie AG: Burden of disease: medical and economic impact of acute coronary syndromes. Am J Manag Care 2006, 12:S430-S434.
  • [23]Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KA, Goldberg RJ, Anderson FA Jr: The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009, 158:193-201.
  • [24]Johnston SS, Curkendall S, Makenbaeva D, Mozaffari E, Goetzel R, Burton W, Maclean R: The direct and indirect cost burden of acute coronary syndrome. J Occup Environ Med 2011, 53:2-7.
  • [25]Berenson K, Ogbonnaya A, Casciano R, Makenbaeva D, Mozaffari E, Lamerato L, Corbelli J: Economic consequences of ACS-related rehospitalizations in the US. Curr Med Res Opin 2010, 26:329-336.
  • [26]Rizzello V, Lucci D, Maggioni AP, Giampaoli S, Greco C, Pasquale GD, Pallotti MG, Mureddu GF, Chiara AD, Boccanelli A: Clinical epidemiology, management and outcome of acute coronary syndromes in the Italian network on acute coronary syndromes (IN-ACS Outcome study). Acute Card Care 2012, 14:71-80.
  • [27]Xanthopoulou I, Davlouros P, Tsigkas G, Panagiotou A, Hahalis G, Alexopoulos D: Long-term clinical outcome after percutaneous coronary intervention in grafts vs native vessels in patients with previous coronary artery bypass grafting. Can J Cardiol 2011, 27:716-724.
  • [28]Patel M, Kim M, Karajgikar R, Kodali V, Kaplish D, Lee P, Moreno P, Krishnan P, Sharma SK, Kini AS: Outcomes of patients discharged the same day following percutaneous coronary intervention. JACC Cardiovasc Interv 2010, 3:851-858.
  • [29]Rao SV, Kaltenbach LA, Weintraub WS, Roe MT, Brindis RG, Rumsfeld JS, Peterson ED: Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. JAMA 2011, 306:1461-1497.
  • [30]Ranchord AM, Prasad S, Seneviratne SK, Simmonds MB, Matsis P, Aitken A, Harding SA: Same-day discharge is feasible and safe in the majority of elderly patients undergoing elective percutaneous coronary intervention. J Invasive Cardiol 2010, 22:301-305.
  文献评价指标  
  下载次数:12次 浏览次数:11次